Breaking News Instant updates and real-time market news.

MMM

3M

$165.11

-4.07 (-2.41%)

, MAR

Marriott

$138.16

-3.19 (-2.26%)

10:19
07/09/19
07/09
10:19
07/09/19
10:19

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. 3M (MMM) downgraded to Sector Perform from Outperform at RBC Capital with analyst Deane Dray expecting the overhang on the shares from macro pressures and litigation to persist. 2. Marriott (MAR) and Hilton (HLT) downgraded to Neutral from Overweight at JPMorgan, while Ryman Hospitality (RHP) and CorePoint Lodging (CPLG) were downgraded to Underweight from Neutral. 3. Alcoa (AA) downgraded to Neutral from Outperform at Macquarie. 4. First Business Financial (FBIZ) downgraded to Neutral from Buy at DA Davidson with analyst Kevin Reevey saying the rating change is driven purely by the recent 33% advance in the stock price from its 52-week lows to within 6% of its 52-week highs. 5. Myriad Genetics (MYGN) downgraded to Market Perform from Outperform at Cowen with analyst Doug Schenkel citing a combination of lower overall conviction in Myriad and a less attractive relative valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

MMM

3M

$165.11

-4.07 (-2.41%)

MAR

Marriott

$138.16

-3.19 (-2.26%)

HLT

Hilton

$99.01

-1.23 (-1.23%)

RHP

Ryman Hospitality

$79.00

-1.665 (-2.06%)

CPLG

CorePoint Lodging

$12.29

-0.62 (-4.80%)

AA

Alcoa

$21.41

-0.9 (-4.03%)

FBIZ

First Business Financial

$24.59

-0.41 (-1.64%)

MYGN

Myriad Genetics

$26.62

-0.6 (-2.20%)

  • 17

    Jul

  • 24

    Jul

  • 25

    Jul

  • 06

    Aug

  • 06

    Aug

  • 13

    Nov

MMM 3M
$165.11

-4.07 (-2.41%)

06/20/19
RBCM
06/20/19
INITIATION
Target $80
RBCM
Sector Perform
DuPont initiated with a Sector Perform at RBC Capital
RBC Capital analyst Arun Viswanathan initiated DuPont (DD) with a Sector Perform rating and a price target of $80 after its completed spin-offs, saying the current valuation asks investors for a "leap of faith" with multiples comparable to multi-industry peers like 3M (MMM) and Honeywell (HON). The analyst notes that although the company's improvements are "tangible", he also sees its prospects as more dependent on the macro conditions. Given the softer auto and smartphone demand in China, Viswanathan prefers to have "greater confidence" in DuPont performance before assigning a higher multiple.
07/08/19
RBCM
07/08/19
DOWNGRADE
RBCM
Sector Perform
3M downgraded to Sector Perform from Outperform at RBC Capital
06/27/19
DBAB
06/27/19
NO CHANGE
DBAB
Buy
Corning 'fundamentally undervalued' relative to peers, says Deutsche Bank
Corning's (GLW) glass innovations and growth opportunities ahead merit an "innovation premium," Deutsche Bank analyst Vijay Bhagavath tells investors in a research note. At current share levels, Corning is "fundamentally undervalued" relative to tech industrials peers like Keysight Technologies (KEYS), Motorola Solutions (MSI), 3M (MMM) and Amphenol (APH), adds the analyst. Bhagavath keeps a Buy rating on shares of Corning.
07/09/19
RBCM
07/09/19
DOWNGRADE
Target $176
RBCM
Sector Perform
With reputation 'eroding,' RBC downgrades 3M to Sector Perform
RBC Capital analyst Deane Dray last night downgraded 3M Company to Sector Perform from Outperform and lowered his price target for the shares to $176 from $207. The stock closed Monday down 2% to $169.19. The analyst expects the overhang on the shares from macro pressures and litigation to persist. After an "unsettling string" of guidance cuts, 3M's reputation as a "defensive, high-quality industrial is eroding," Dray tells investors in a research note. Further, PFAS litigation remains an "unquantifiable risk" that is likely to worsen as the product liability class actions escalate, adds the analyst. Dray also sees risk of more guidance cuts from 3M as well as limited capital allocation catalysts.
MAR Marriott
$138.16

-3.19 (-2.26%)

04/24/19
04/24/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Harley-Davidson (HOG) downgraded to Sell from Neutral at Goldman Sachs with analyst David Tamberrino saying he views Harley as the "worst positioned" within his Powersports coverage given its concentration in a "secularly declining" motorcycle market. 2. TowerJazz (TSEM) downgraded to Neutral from Outperform at Credit Suisse with analyst Quang Tung Le saying to reflect ongoing weakness at the company's "key" radio frequency and power customers along with revised three- year deal extension with Panasonic, the analyst reduced his sales estimates. 3. Marriott (MAR) downgraded to In Line from Outperform at Evercore ISI with analyst Rich Hightower saying approaching Q1 earnings season, the analyst finds himself "incrementally negative" on hotel stocks overall - and even more so with respect to the C-Corps than the REITs - given the sector's substantial recent outperformance against the relevant benchmarks, coupled with no obvious shift in fundamentals over the last 60-90 days. 4. Kraft Heinz (KHC) downgraded to Underweight from Neutral at Piper Jaffray with analyst Michael Lavery saying expectations for the company's 2020 earnings are likely too high as it plans divestitures of underperforming businesses, which could be 20c-30c dilutive on a per share basis. 5. Hyatt (H) and Hilton (HLT) downgraded to Market Perform from Outperform at Wells Fargo. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/24/19
04/24/19
DOWNGRADE

In Line
Marriott downgraded to In Line on valuation at Evercore ISI
As previously reported, Evercore ISI analyst Rich Hightower downgraded Marriott to In Line from Outperform primarily on valuation. Approaching Q1 earnings season, the analyst finds himself "incrementally negative" on hotel stocks overall - and even more so with respect to the C-Corps than the REITs - given the sector's substantial recent outperformance against the relevant benchmarks, coupled with no obvious shift in fundamentals over the last 60-90 days.
07/09/19
JPMS
07/09/19
DOWNGRADE
Target $138
JPMS
Neutral
Marriott downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Joseph Greff downgraded Marriott International to Neutral from Overweight with an unchanged price target of $138. The analyst is "increasingly cautious" on valuations in the Lodging space as well as the length of the current cycle.
07/09/19
JPMS
07/09/19
DOWNGRADE
JPMS
JPMorgan 'increasingly cautious' on Lodging, downgrades four names
JPMorgan analyst Joseph Greff is "increasingly cautious" on valuations in the Lodging space. Recent share performance, "peak" valuations, an extended cycle and decelerating industry trends all point to "diminished upside" from current share levels, Greff tells investors in a research note. On "more even" risk/reward profiles, the analyst downgraded both Marriott (MAR) and Hilton (HLT) to Neutral from Overweight. Greff also downgraded both Ryman Hospitality (RHP) and CorePoint Lodging (CPLG) to Underweight from Neutral as he sees more risk to the downside. The analyst's only remaining Overweight-rated names are Wyndham Hotels & Resorts (WH) and Extended Stay America (STAY).
HLT Hilton
$99.01

-1.23 (-1.23%)

05/13/19
BREN
05/13/19
DOWNGRADE
BREN
Hold
Hilton downgraded to Hold from Buy at Berenberg
07/09/19
JPMS
07/09/19
DOWNGRADE
Target $102
JPMS
Neutral
Hilton downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Joseph Greff downgraded Hilton Worldwide to Neutral from Overweight with an unchanged price target of $102. The analyst is "increasingly cautious" on valuations in the Lodging space as well as the length of the current cycle.
05/06/19
05/06/19
DOWNGRADE
Target $102

Outperform
Hilton downgraded to Outperform on valuation at Raymond James
As previously reported, Raymond James downgraded Hilton to Outperform from Strong Buy and raised its price target to $102 from $92 following the Q1 beat and raise report. Analyst William Crow said Hilton is "firing on all cylinders," but changed his view one notch to reflect valuation.
RHP Ryman Hospitality
$79.00

-1.665 (-2.06%)

01/08/19
RAJA
01/08/19
UPGRADE
RAJA
Outperform
Ryman Hospitality upgraded to Outperform from Market Perform at Raymond James
07/09/19
JPMS
07/09/19
DOWNGRADE
Target $77
JPMS
Underweight
Ryman Hospitality downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Joseph Greff downgraded Ryman Hospitality to Underweight from Neutral and lowered his price target for the shares to $77 from $80. The analyst is "increasingly cautious" on valuations in the Lodging space as well as the length of the current cycle.
CPLG CorePoint Lodging
$12.29

-0.62 (-4.80%)

07/09/19
JPMS
07/09/19
DOWNGRADE
Target $11
JPMS
Underweight
CorePoint Lodging downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Joseph Greff downgraded CorePoint Lodging to Underweight from Neutral and lowered his price target for the shares to $11 from $13. The analyst is "increasingly cautious" on valuations in the Lodging space as well as the length of the current cycle.
10/15/18
JPMS
10/15/18
INITIATION
Target $16
JPMS
Underweight
CorePoint Lodging initiated with an Underweight at JPMorgan
JPMorgan analyst Omer Sander started CorePoint Lodging with an Underweight rating and $16 price target. The analyst sees almost 10% downside potential on the company's single-branded, geographically concentrated portfolio" and its "consistent" RevPAR underperformance.
01/09/19
JPMS
01/09/19
UPGRADE
Target $14
JPMS
Neutral
CorePoint Lodging upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Joseph Greff upgraded CorePoint Lodging to Neutral while lowering his price target for the shares to $14 from $16. The analyst sees a more balanced risk/reward profile at current valuation levels. CorePoint has traded down 50% since its spin out on May 31, 2018, the analyst points out.
AA Alcoa
$21.41

-0.9 (-4.03%)

04/22/19
GABE
04/22/19
UPGRADE
GABE
Buy
Alcoa upgraded to Buy from Hold at Gabelli
04/22/19
04/22/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. IPG Photonics (IPGP) upgraded to Buy from Neutral at BofA/Merrill. 2. Caleres (CAL) upgraded to Buy from Hold at Needham with analyst Rick Patel saying that his recent meeting with its CEO and CFO have given him an added confidence about the FY19 EPS guidance being "achievable and likely beatable." 3. Viavi (VIAV) upgraded to Neutral from Underweight at JPMorgan with analyst Samik Chatterjee saying the "buildup of industry tailwinds" in the form of 5G network deployments as well as fiber densification and adoption of 3D Sensing should drive medium-term growth above expectations. 4. Alcoa (AA) upgraded to Buy from Hold at Gabelli. 5. Lam Research (LRCX) upgraded to Buy from Neutral at B. Riley FBR with analyst Craig Ellis saying he sees "increasingly visible recent signs" of a cyclical trough in Q1. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/09/19
MACQ
07/09/19
DOWNGRADE
Target $25
MACQ
Neutral
Alcoa downgraded to Neutral from Outperform at Macquarie
Macquarie analyst David Lipschitz downgraded Alcoa to Neutral from Outperform and lowered his price target on the stock to $25 from $34.
06/19/19
DBAB
06/19/19
NO CHANGE
DBAB
Buy
Constellium a winner of upcoming can sheet shortage, says Deutsche Bank
The stable demand of aluminum beverage can sheet along with little-to-no investment by production companies has tightened markets, Deutsche Bank analyst Jeremy Kliewer tells investors in a research note. The analyst believes that as legacy can sheet contracts roll-off, new contracts are likely to reflect the tightened supply dynamics through higher pricing. With roughly 50% of Constellium's (CSTM) production/shipment volumes exposed to aluminum can sheet, Kliewer sees the company as the largest beneficiary of upcoming can sheet prices increasing. He raised his 2020-2021 EBITDA estimates by 5% to reflect the company's packaging sheet margins widening and recommends buying the shares. The analyst reiterates a Buy ratings on Constellium and Alcoa (AA), as well as packaging companies Ball Corp. (BLL), Crown Holdings (CCK) and Ardagh Group (ARD).
FBIZ First Business Financial
$24.59

-0.41 (-1.64%)

07/09/19
DADA
07/09/19
DOWNGRADE
DADA
Neutral
First Business Financial downgraded to Neutral from Buy at DA Davidson
08/28/18
DADA
08/28/18
UPGRADE
Target $26.5
DADA
Buy
First Business Financial upgraded to Buy at DA Davidson on valuation
As reported earlier, DA Davidson analyst Kevin Reevey upgraded First Business Financial to Buy from Neutral and kept his price target at $26.50. The analyst notes that the current trading level on the stock presents an attractive entry point after its 10% month-to-date decline and a 19% retreat from its 52-week highs. Reevey adds that First Business Financial valuation also presents a 26% discount to the peer group, which makes it "one of the least expensive names" in his Midwest coverage universe. The analyst is also positive on the company's turnaround efforts, with restructuring in its SBA lending business "starting to bear fruit" and producing loan originations and earnings momentum in 2018 and beyond.
08/28/18
08/28/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. RH (RH) upgraded to Accumulate from Hold at Gordon Haskett. 2. Estee Lauder (EL) and Coty (COTY) upgraded to Overweight from Equal Weight at Morgan Stanley. 3. First Business Financial (FBIZ) upgraded to Buy from Neutral at DA Davidson with analyst Kevin Reevey saying the current trading level on the stock presents an attractive entry point after its 10% month-to-date decline and a 19% retreat from its 52-week highs. 4. Regency Centers (REG) upgraded to Buy from Hold at Deutsche Bank with analyst Derek Johnston saying "clear signs" of a retail recovery has fueled the rally in strip real estate investment trusts in recent weeks. 5. Affimed N.V. (AFMD) upgraded to Buy from Hold at Jefferies with analyst Maury Raycroft saying its collaboration with Roche Group's (RHHBY) Genentech to develop and commercialize novel NK cell engagers indicate the intrinsic value in Affimed's platform and approach. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/09/19
DADA
07/09/19
DOWNGRADE
Target $26.5
DADA
Neutral
First Business Financial downgraded to Neutral at DA Davidson on valuation
DA Davidson analyst Kevin Reevey downgraded First Business Financial to Neutral from Buy but kept his $26.50 price target, saying the rating change is driven purely by the recent 33% advance in the stock price from its 52-week lows to within 6% of its 52-week highs. The analyst contends that the run-up has created a profit-taking opportunity, as the forward price to book value divergence between the company and its peers has "narrowed considerably".
MYGN Myriad Genetics
$26.62

-0.6 (-2.20%)

07/09/19
COWN
07/09/19
DOWNGRADE
Target $30
COWN
Market Perform
Myriad Genetics downgraded to Market Perform from Outperform at Cowen
Cowen analyst Doug Schenkel downgraded Myriad Genetics to Market Perform from Outperform and lowered his price target for the shares to $30 from $37, citing a combination of lower overall conviction in Myriad and a less attractive relative valuation. In a research note to investors, Schenkel says that while many key pillars to his January 2019 upgrade remain "somewhat intact," Myriad's year-to-date execution has not been completely spotless and there have been some negative developments.
07/09/19
COWN
07/09/19
DOWNGRADE
COWN
Market Perform
Myriad Genetics downgraded to Market Perform from Outperform at Cowen
Cowen analyst Doug Schenkel downgraded Myriad Genetics to Market Perform from Outperform.
06/14/19
LEHM
06/14/19
NO CHANGE
Target $18
LEHM
Underweight
Myriad Genetics price target lowered to $18 from $20 at Barclays
Barclays analyst Jack Meehan lowered his price target for Myriad Genetics to $18 from $20 and keeps an Underweight rating on the shares. The analyst now sees a probability of GeneSight non-coverage of 35% versus his prior view of 20%. He believes several Medicare Administrative Contractors hosting on June 26 a multi-jurisdictional Contractor Advisory Committee meeting to discuss pharmacogenomics in psychiatry raises the risk of GeneSight's "downside case."
05/30/19
PIPR
05/30/19
NO CHANGE
Target $45
PIPR
Overweight
Myriad Genetics trading 'well below slower growing' peers, says Piper Jaffray
Piper Jaffray analyst William Quirk says Myriad Genetics (MYGN) management remains optimistic over incremental private payer coverage for GeneSight, but points out they are now guiding to finalized decisions by calendar year end, which is about three-to-six months later than his previous expectations. Quirk suspects the negotiations are taking longer than expected due to the study dynamics. The analyst, while appreciating investors' frustration over Myriad shares, believes the stock is trading "well below slower growing" LabCorp (LH) and Quest Diagnostics (DGX). A couple reimbursement wins will be enough to create a rally, Quirk tells investors in a research note. He keeps an Overweight rating on Myriad Genetics with a $45 price target.

TODAY'S FREE FLY STORIES

PYPL

PayPal

$118.65

-1.22 (-1.02%)

, V

Visa

$179.18

-1.34 (-0.74%)

08:31
07/20/19
07/20
08:31
07/20/19
08:31
Periodicals
MasterCard, Visa among best stocks to play fintech boom, Barron's says »

The fintech units within…

PYPL

PayPal

$118.65

-1.22 (-1.02%)

V

Visa

$179.18

-1.34 (-0.74%)

MA

MasterCard

$275.51

-1.11 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 24

    Jul

  • 30

    Jul

USB

U.S. Bancorp

$54.98

-0.2 (-0.36%)

, SBNY

Signature Bank

$123.87

1.07 (0.87%)

08:28
07/20/19
07/20
08:28
07/20/19
08:28
Periodicals
KeyCorp, U.S. Bancorp better positioned for Fed rate cut, Barron's says »

KeyCorp (KEY), Signature…

USB

U.S. Bancorp

$54.98

-0.2 (-0.36%)

SBNY

Signature Bank

$123.87

1.07 (0.87%)

KEY

KeyCorp

$17.45

0.15 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 29

    Aug

  • 16

    Oct

CMG

Chipotle

$746.80

-17.43 (-2.28%)

08:24
07/20/19
07/20
08:24
07/20/19
08:24
Periodicals
Chipotle stock made 'stunning' comeback, Barron's says »

Chipotle's stock is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 25

    Sep

BYND

Beyond Meat

$176.65

6.28 (3.69%)

07:40
07/20/19
07/20
07:40
07/20/19
07:40
Periodicals
Beyond Meat could spike after earnings, Barron's says »

After rising so…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

NFLX

Netflix

$315.10

-10.04 (-3.09%)

07:37
07/20/19
07/20
07:37
07/20/19
07:37
Periodicals
Netflix's problems have only just begun, Barron's says »

Netflix has a problem and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

, TGT

Target

$88.02

-0.48 (-0.54%)

07:34
07/20/19
07/20
07:34
07/20/19
07:34
Periodicals
Time to aim higher on Target's stock, Barron's says »

As retailers have…

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

TGT

Target

$88.02

-0.48 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 21

    Aug

  • 19

    Sep

  • 25

    Sep

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

, FDX

FedEx

$167.08

1.69 (1.02%)

07:31
07/20/19
07/20
07:31
07/20/19
07:31
Periodicals
FedEx ups game amid e-commerce growth, Barron's says »

It is time to embrace…

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

FDX

FedEx

$167.08

1.69 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

  • 17

    Sep

  • 13

    Nov

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

, MSFT

Microsoft

$136.62

0.33 (0.24%)

07:27
07/20/19
07/20
07:27
07/20/19
07:27
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

MSFT

Microsoft

$136.62

0.33 (0.24%)

ORCL

Oracle

$57.55

-0.58 (-1.00%)

AZN

AstraZeneca

$40.11

-0.61 (-1.50%)

BMY

Bristol-Myers

$43.32

-0.72 (-1.63%)

LLY

Eli Lilly

$106.75

-1.57 (-1.45%)

GSK

GlaxoSmithKline

$40.97

-0.44 (-1.06%)

JNJ

Johnson & Johnson

$130.41

-1.62 (-1.23%)

MRK

Merck

$81.39

-1.28 (-1.55%)

NVS

Novartis

$93.58

-0.715 (-0.76%)

PFE

Pfizer

$42.78

-0.28 (-0.65%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$41.94

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 29

    Jul

  • 30

    Jul

  • 30

    Jul

  • 30

    Jul

  • 03

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 27

    Aug

  • 28

    Aug

  • 02

    Sep

  • 09

    Sep

  • 16

    Sep

  • 16

    Sep

  • 20

    Sep

  • 23

    Sep

  • 25

    Sep

  • 02

    Oct

  • 15

    Oct

  • 04

    Nov

BHVN

Biohaven Pharmaceutical

$44.16

-0.61 (-1.36%)

18:12
07/19/19
07/19
18:12
07/19/19
18:12
Hot Stocks
Biohaven receives CRL from FDA for application seeking NURTEC approval »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

CE

Celanese

$107.01

0.9 (0.85%)

18:01
07/19/19
07/19
18:01
07/19/19
18:01
Hot Stocks
Celanese announces acetyl intermediates price increases »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

F

Ford

$10.20

-0.06 (-0.58%)

17:48
07/19/19
07/19
17:48
07/19/19
17:48
Periodicals
Ford plans to lay off 185 employees at Ontario plant, Reuters reports »

A union local said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 23

    Oct

RTN

Raytheon

$178.55

2.45 (1.39%)

17:48
07/19/19
07/19
17:48
07/19/19
17:48
Hot Stocks
Raytheon awarded $191.01M Air Force contract modification »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

UTX

United Technologies

$132.37

1.08 (0.82%)

17:44
07/19/19
07/19
17:44
07/19/19
17:44
Hot Stocks
United Technologies awarded $253.71M Air Force contract »

United Technologies has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

LMT

Lockheed Martin

$356.90

0.675 (0.19%)

17:40
07/19/19
07/19
17:40
07/19/19
17:40
Hot Stocks
Lockheed Martin awarded $1.47B Missile Defense Agency contract modification »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

ARES

Ares Management

$28.13

-0.305 (-1.07%)

17:33
07/19/19
07/19
17:33
07/19/19
17:33
Syndicate
Breaking Syndicate news story on Ares Management »

Ares Management files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 06

    Aug

HAFC

Hanmi Financial

$21.68

-0.105 (-0.48%)

17:33
07/19/19
07/19
17:33
07/19/19
17:33
Hot Stocks
Hanmi Financial to delay release of Q2 results »

Hanmi Financial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

PAYS

Paysign

$17.49

-0.48 (-2.67%)

17:32
07/19/19
07/19
17:32
07/19/19
17:32
Syndicate
Breaking Syndicate news story on Paysign »

Paysign files $150M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEOH

Methanex

$43.19

0.83 (1.96%)

17:28
07/19/19
07/19
17:28
07/19/19
17:28
Hot Stocks
Methanex reaches final investment decision on methanol plant in Geismar, LA »

Methanex Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

17:17
07/19/19
07/19
17:17
07/19/19
17:17
Conference/Events
Credit Suisse biotech analysts to hold an analyst/industry conference call »

Biotech Analysts provide…

17:14
07/19/19
07/19
17:14
07/19/19
17:14
Conference/Events
UBS retail/hardlines analyst to hold an analyst/industry conference call »

Retail/Hardlines Analyst…

SHIP

Seanergy Marine

$0.64

-0.0425 (-6.25%)

17:05
07/19/19
07/19
17:05
07/19/19
17:05
Hot Stocks
Seanergy Maritime receives noncompliance notice from Nasdaq »

Seanergy Maritime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SONM

Sonim

$13.42

0.24 (1.82%)

16:41
07/19/19
07/19
16:41
07/19/19
16:41
Conference/Events
Sonim management to meet with Oppenheimer »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 26

    Jul

  • 12

    Sep

KINS

Kingstone Companies

$8.81

0.09 (1.03%)

16:30
07/19/19
07/19
16:30
07/19/19
16:30
Hot Stocks
Kingstone names Barry Goldstein CEO »

Kingstone Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 09

    Aug

16:30
07/19/19
07/19
16:30
07/19/19
16:30
Options
Preliminary option volume of 22.6M today »

Preliminary option volume…

BA

Boeing

$377.34

16.17 (4.48%)

, MSFT

Microsoft

$136.62

0.33 (0.24%)

16:24
07/19/19
07/19
16:24
07/19/19
16:24
On The Fly
Fly Intel: Wall Street's top stories for Friday »

Stocks were tentatively…

BA

Boeing

$377.34

16.17 (4.48%)

MSFT

Microsoft

$136.62

0.33 (0.24%)

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

AAPL

Apple

$202.62

-3.02 (-1.47%)

WMT

Walmart

$113.91

-0.77 (-0.67%)

DIS

Disney

$139.86

-1.76 (-1.24%)

GCI

Gannett

$9.43

1.53 (19.37%)

CRWD

Crowdstrike

$83.50

10.75 (14.78%)

SKX

Skechers

$39.00

4.25 (12.23%)

PACB

Pacific Biosciences

$5.34

-0.53 (-9.03%)

ILMN

Illumina

$293.10

-5.44 (-1.82%)

CHWY

Chewy

$30.70

-2.09 (-6.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 29

    Jul

  • 30

    Jul

  • 03

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 15

    Aug

  • 03

    Sep

  • 25

    Sep

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.